Drug Trial Radar · NCT03806127
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Last checked: Nov 20, 2026Latest source record: Aug 2, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
222
Actual
Start
Dec 31, 2018
Primary completion
Sep 25, 2020
Study completion Oct 6, 2020
Sponsor
- Lead sponsor
- Urovant Sciences GmbHIndustry
- Sponsor type
- Industry
- First posted
- Jan 16, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the efficacy and safety of vibegron, a beta-3 adrenergic receptor (β3-AR) agonist, in the treatment of pain associated with irritable bowel syndrome (IBS) due to IBS with predominant diarrhea (IBS-D) or mixed episodes of diarrhea and constipation (IBS-M).
Conditions
- Irritable Bowel Syndrome
Interventions
VibegronDrug
oral administration
PlaceboDrug
oral administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Irritable Bowel Syndrome (IBS) With Predominantly Diarrhea (IBS-D) Participants Who Were Abdominal Pain Intensity (API) Weekly Responders at Week 12Time frame: Baseline; Week 12
Locations
41 sites in 1 country. Site status is shown where the registry gives one.
Synexus Clinical Research US, Inc.-Simon Williamson Clinic
Birmingham, Alabama
Clinical Research Associates
Huntsville, Alabama
Alabama Medical Group, PC
Mobile, Alabama
Hope Research Institute
Chandler, Arizona
Synexus Clinical Research US, Inc. - East Valley Family Physicians, PLC
Chandler, Arizona
Synexus Clinical Research US, Inc. - Central Arizona Medical Associates, PC
Mesa, Arizona
Synexus Clinical Research US, Inc. - Desert Clinical Research, LLC
Mesa, Arizona
Synexus - Clinical Research Advantage, Inc. - Central Phoenix Medical Clinic LLC
Phoenix, Arizona
GW Research Inc - ClinEdge-PPDS
Chula Vista, California
Triwest Research Associates, LLC
La Mesa, California
VA Long Beach Healthcare System - NAVREF
Long Beach, California
Southern California Research Institute Medical Group, Inc.
Los Angeles, California
Desta Digestive Disease Medical Center
San Diego, California
Medical Associates Research Group, Inc.
San Diego, California
Torrance Clinical Research
Torrance, California
Medical Research Center of Connecticut LLC
Hamden, Connecticut
Mayo Clinic - Division of Gastroenterology
Jacksonville, Florida
Florida Center For Gastroenterology
Largo, Florida
Clinical Research Center of Florida
Pompano Beach, Florida
Palm Beach Research - ClinEdge - PPDS
West Palm Beach, Florida
RNA America, LLC
Sugar Hill, Georgia
Investigators Research Group, LLC
Indianapolis, Indiana
Mandeville Private Physician Group, LLC
Mandeville, Louisiana
Massachusetts General Hospital
Boston, Massachusetts
University of Michigan
Ann Arbor, Michigan
Clinical Research Institute of Michigan
Chesterfield, Michigan
Synexus Clinical Research US, Inc. - Rita B. Chuang, MD, LLC
Henderson, Nevada
Advanced Research Institute
Reno, Nevada
Atrium Healthcare Center for Digestive Health
Charlotte, North Carolina
Carolina Digestive Diseases
Greenville, North Carolina
East Carolina Gastroenterology
Jacksonville, North Carolina
Dayton Gastroenterology, Inc.
Beavercreek, Ohio
Central Sooner Research
Norman, Oklahoma
Synexus Clinical Research US, Inc. - Anderson
Anderson, South Carolina
Chattanooga Medical Research Inc
Chattanooga, Tennessee
Clinical Research Solutions PC
Jackson, Tennessee
DHAT Research Institute
Garland, Texas
University of Texas Health Science Center at Houston
Houston, Texas
Synexus Clinical Research US, Inc.-Plano
Plano, Texas
Synexus Clinical Research US, Inc. - Wasatch Peak Family Practice
Layton, Utah
Showing 40 of 41 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.